Literature DB >> 20730487

Body weight and risk of breast cancer in BRCA1/2 mutation carriers.

Peggy Manders1, Anouk Pijpe, Maartje J Hooning, Irma Kluijt, Hans F A Vasen, Nicoline Hoogerbrugge, Christi J van Asperen, Hanne Meijers-Heijboer, Margreet G E M Ausems, Theo A van Os, Encarna B Gomez-Garcia, Richard M Brohet, Flora E van Leeuwen, Matti A Rookus.   

Abstract

Obesity is an established risk factor for postmenopausal breast cancer in the general population. However, it is still unclear whether this association also exists in BRCA1/2 mutation carriers. We investigated the association between self-reported anthropometric measures and breast cancer risk in a nationwide retrospective cohort study, including 719 BRCA1/2 carriers, of whom 218 had been diagnosed with breast cancer within 10 years prior to questionnaire completion. All time-varying Cox proportional hazards analyses were stratified by menopausal status. For premenopausal breast cancer, no statistically significant associations were observed for any of the anthropometric measures. The association between body mass index (BMI) at age 18 and premenopausal breast cancer risk suggested a trend of decreasing risk with increasing BMI (HR(22.50-24.99 vs. 18.50-22.49) = 0.83, 95% CI = 0.47-1.44 and HR(≥ 25.00 vs. 18.50-22.49) = 0.41, 95% CI = 0.13-1.27). For postmenopausal breast cancer, being 1.67 m and taller increased the risk 1.7-fold (HR = 1.67, 95% CI = 1.01-2.74) when compared to a height <1.67 m. Compared with a current body weight < 72 kg, a current body weight of ≥ 72 kg increased the risk of postmenopausal breast cancer 2.1-fold (95% CI = 1.23-3.59). A current BMI of ≥ 25.0 kg/m², an adult weight gain of 5 kg or more, and a relative adult weight gain of 20% or more were all non-significantly associated with a 50-60% increased risk of postmenopausal breast cancer [HR = 1.46 (0.86-2.51), HR = 1.56 (95% CI = 0.85-2.87), and HR = 1.60 (95% CI = 0.97-2.63), respectively], when compared with having a healthy or stable weight. No associations for body weight or BMI at age 18 were observed. In conclusion, menopausal status seemed to modify the association between body weight and breast cancer risk among BRCA1/2 carriers. We observed no clear association between body weight and premenopausal breast cancer, while overweight and weight gain increased postmenopausal breast cancer risk. Carriers may reduce their risk of postmenopausal breast cancer by maintaining a healthy body weight throughout life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20730487     DOI: 10.1007/s10549-010-1120-8

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  28 in total

1.  Does and should breast cancer genetic counselling include lifestyle advice?

Authors:  Akke Albada; Madelèn Vernooij; Liesbeth van Osch; Anouk Pijpe; Sandra van Dulmen; Margreet G E M Ausems
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

2.  Global burden of disease study is of oncological interest.

Authors:  Matthias J Wenderlein
Journal:  Dtsch Arztebl Int       Date:  2015-03-20       Impact factor: 5.594

3.  Lifestyle Interventions for Breast Cancer Prevention.

Authors:  Justin C Brown; Jennifer A Ligibel
Journal:  Curr Breast Cancer Rep       Date:  2018-07-03

4.  Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.

Authors:  Nancy U Lin; Ann Vanderplas; Melissa E Hughes; Richard L Theriault; Stephen B Edge; Yu-Ning Wong; Douglas W Blayney; Joyce C Niland; Eric P Winer; Jane C Weeks
Journal:  Cancer       Date:  2012-04-27       Impact factor: 6.860

Review 5.  Weight management and its role in breast cancer rehabilitation.

Authors:  Wendy Demark-Wahnefried; Kristin L Campbell; Sandra C Hayes
Journal:  Cancer       Date:  2012-04-15       Impact factor: 6.860

6.  Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers.

Authors:  Shana J Kim; Tomasz Huzarski; Jacek Gronwald; Christian F Singer; Pål Møller; Henry T Lynch; Susan Armel; Beth Y Karlan; William D Foulkes; Susan L Neuhausen; Leigha Senter; Andrea Eisen; Charis Eng; Seema Panchal; Tuya Pal; Olufunmilayo Olopade; Dana Zakalik; Jan Lubinski; Steven A Narod; Joanne Kotsopoulos
Journal:  Int J Epidemiol       Date:  2018-06-01       Impact factor: 7.196

7.  BRCA1 polymorphisms and breast cancer epidemiology in the Western New York exposures and breast cancer (WEB) study.

Authors:  Luisel J Ricks-Santi; Jing Nie; Catalin Marian; Heather M Ochs-Balcom; Maurizio Trevisan; Stephen B Edge; Yasmine Kanaan; Jo L Freudenheim; Peter G Shields
Journal:  Genet Epidemiol       Date:  2013-05-14       Impact factor: 2.135

8.  The Dose-Response Effects of Aerobic Exercise on Body Composition and Breast Tissue among Women at High Risk for Breast Cancer: A Randomized Trial.

Authors:  Justin C Brown; Despina Kontos; Mitchell D Schnall; Shandong Wu; Kathryn H Schmitz
Journal:  Cancer Prev Res (Phila)       Date:  2016-04-20

9.  Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.

Authors:  Carol J Fabian; Bruce F Kimler; Joseph E Donnelly; Debra K Sullivan; Jennifer R Klemp; Brian K Petroff; Teresa A Phillips; Trina Metheny; Sonya Aversman; Hung-Wen Yeh; Carola M Zalles; Gordon B Mills; Stephen D Hursting
Journal:  Breast Cancer Res Treat       Date:  2013-10-19       Impact factor: 4.872

10.  A randomized controlled trial of diet and physical activity in BRCA mutation carriers.

Authors:  P Pasanisi; E Bruno; S Manoukian; F Berrino
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.